NCT06703008 Intraoperatory Hemodynamic Monitoring in OLT
| NCT ID | NCT06703008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Liver Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-11-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare two different hemodynamic monitoring techniques during orthotopic liver transplantation. The main question it aims to answer is: if using a different hemodynamic monitoring might help reducing the intraoperative hypotension time. Participants will be randomized to one of two arms of hemodynamic monitoring: * conventional monitoring with pulmonary artery catheter * monitoring with transesophageal echocardiography Researchers will compare the two groups to see if there is any difference in the intraoperatory hypotension time and in secondary outcomes such as organ dysfunctions or mortality.
Eligibility Criteria
Inclusion Criteria: * Candidate for Liver Transplantation * Acceptance of informed consent to participate in the study. Exclusion Criteria: * Bleeding esophageal varices * Bleeding gastro-esophageal ulcer * Gastro-esophageal anomalies (congenital, acquired or post-surgical)
Contact & Investigator
Amedeo Bianchini, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06703008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06703008 currently recruiting?
Yes, NCT06703008 is actively recruiting participants. Contact the research team at amedeo.bianchini@aosp.bo.it for enrollment information.
Where is the NCT06703008 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06703008 clinical trial?
NCT06703008 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Amedeo Bianchini, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 180 participants.